 |
Media Release
Ad-hoc- announcement pursuant to Art. 53 LR
Altstätten, 16 January 2026
COLTENE publishes preliminary key figures for financial year 2025
COLTENE Holding AG, a leading international developer and manufacturer of dental consumables and small equipment, achieved consolidated sales of CHF 240.2 million in fiscal year 2025 according to preliminary figures (2024: CHF 250.2 million). In local currencies, this is roughly on par with the previous year (-0.2%). In the reporting currency, sales declined by -4.0% due to unfavourable exchange rate effects, particularly the appreciation of the Swiss franc. The EBIT margin for the past financial year was 8.8%.
In the second half of 2025, the expected sales recovery materialised with growth of 4.7% in local currencies, after the first half had been impacted by geopolitical factors and temporary order delays related to the optimization of dealer management. The general market restraint persisted. In the North America region, this resulted in a slight decline in sales in local currencies, while the EMEA (Europe, Middle East, and Asia) region recorded an increase.
COLTENE anticipates an EBIT margin of 8.8% for the 2025 financial year (2024: 10.7%). Despite further reductions in operating costs, the continued strength of the Swiss franc and advance payments related to US tariffs exerted pressure on the gross margin.
COLTENE remains committed to its previously announced medium-term targets. The company will release detailed information on the business performance in 2025 and its outlook for 2026 with the publication of its 2025 annual report on March 6, 2026.
Contact Investor Relations
Markus Abderhalden, CFO
Phone +41 71 757 54 80
Mobile +41 79 436 26 22
Email markus.abderhalden@coltene.com
To receive regular updates on the latest information about COLTENE Holding AG, please register at invest.coltene.com.
|
Financial calendar |
|
|
Release of Annual Report and Media and analyst conference on the financial results 2025 |
6 March 2026 |
|
Annual General Meeting 2026 |
21 April 2026 |
|
Release Half-Year Report and Media and analyst conference on the half-year results 2026 |
31 July 2026 |
About COLTENE
COLTENE is an international developer, manufacturer, and seller of dental consumables and small equipment in the areas of Infection Control, Dental Improvement, and Treatment Auxiliaries. COLTENE has state-of-the-art production facilities in the USA, Canada, Germany, France, Hungary and Switzerland as well as own sales organizations in all major markets including Europe, North and Latin America, Japan, China, and India. Dentists, DSOs, dental clinics, and dental labs all around the globe trust COLTENE’s high-quality products. The registered shares of COLTENE Holding AG (CLTN) are listed on SIX Swiss Exchange. Learn more about COLTENE and our products at www.coltene.com.
Contact
COLTENE Holding AG
Feldwiesenstrasse 20
CH-9450 Altstätten
P +41 71 757 53 00
This written statement and oral statements or other statements made, or to be made, by us contain forward-looking statements that do not relate solely to historical or current facts. These forward-looking statements are based on the current plans and expectations of our management and are subject to a number of uncertainties and risks that could significantly affect our current plans and expectations, as well as future results of operations and financial conditions. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.